Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies

English version České info

Using longitudinal data, Reecha Sofat and colleagues probe the association between blood levels of ApoE and risk of cardiovascular disease.

Vyšlo v časopise: Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies. PLoS Med 13(10): e32767. doi:10.1371/journal.pmed.1002146
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002146

Souhrn

Using longitudinal data, Reecha Sofat and colleagues probe the association between blood levels of ApoE and risk of cardiovascular disease.

Zdroje

1. Blum CB (1982) Dynamics of apolipoprotein E metabolism in humans. J Lipid Res 23: 1308–1316. 7161560

2. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622–630. doi: 10.1126/science.3283935 3283935

3. Utermann G (1975) Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem 356: 1113–1121. doi: 10.1515/bchm2.1975.356.2.1113 172422

4. Rall SC Jr, Weisgraber KH, Mahley RW (1982) Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257: 4171–4178. 7068630

5. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, et al. (1986) Familial apolipoprotein E deficiency. J Clin Invest 78: 1206–1219. doi: 10.1172/JCI112704 3771793

6. Hofker MH, van Vlijmen BJ, Havekes LM (1998) Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137: 1–11. doi: 10.1016/S0021-9150(97)00266-9 9568731

7. Vincent-Viry M, Schiele F, Gueguen R, Bohnet K, Visvikis S, Siest G (1998) Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem 44: 957–965. 9590368

8. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298: 1300–1311. doi: 10.1001/jama.298.11.1300 17878422

9. Mooijaart SP, Berbee JF, van Heemst D, Havekes LM, de Craen AJ, Slagboom PE, et al. (2006) ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 3: e176. doi: 10.1371/journal.pmed.0030176 16671834

10. van Vliet P, Mooijaart SP, de Craen AJ, Rensen PC, van Heemst D, Westendorp RG (2007) Plasma levels of apolipoprotein E and risk of stroke in old age. Ann N Y Acad Sci 1100: 140–147. doi: 10.1196/annals.1395.012 17460172

11. Corsetti JP, Gansevoort RT, Bakker SJ, Navis G, Sparks CE, Dullaart RP (2012) Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism 61: 996–1002. doi: 10.1016/j.metabol.2011.11.010 22225956

12. McKay GJ, Silvestri G, Chakravarthy U, Dasari S, Fritsche LG, Weber BH, et al. (2011) Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol 173: 1357–1364. doi: 10.1093/aje/kwr015 21498624

13. Ioannidis JP, Trikalinos TA (2005) Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 58: 543–549. doi: 10.1016/j.jclinepi.2004.10.019 15878467

14. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD (1996) Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 75: 767–771. 8725721

15. Marmot MG (2003) Health, wealth and lifestyles of the older population in England: the 2002 English Longitudinal Study of Ageing. London: Institute for Fiscal Studies. 374 p.

16. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366: 895–906. doi: 10.1016/S0140-6736(05)67185-1 16154016

17. Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2015) Plasma levels of apolipoprotein E and risk of dementia in the general population. Ann Neurol 77: 301–311. doi: 10.1002/ana.24326 25469919

18. Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2016) Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. Atherosclerosis 246: 63–70. doi: 10.1016/j.atherosclerosis.2015.12.038 26761769

19. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45: 1452–1458. doi: 10.1038/ng.2802 24162737

20. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45: 433–439. doi: 10.1038/ng.2578 23455636

21. Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, et al. (1981) Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68: 1075–1085. doi: 10.1172/JCI110330 6270194

22. Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257: 2518–2521. 6277903

23. Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, et al. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269: 22358–22365. 8071364

24. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268–285. 3985008

25. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707–713. doi: 10.1038/nature09270 20686565

26. Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, et al. (2009) Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 85: 628–642. doi: 10.1016/j.ajhg.2009.10.014 19913121

27. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, et al. (2011) Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 342: d548. doi: 10.1136/bmj.d548 21325005